Emergent Biosolutions Inc (EBS)
Operating Cash Flow Growth
-47.27%
Quarterly · Period ending:
EBS Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-47.27%period ending
Latest reported-47.27%period ending
EBS Quarterly Cash from Operations YoY % (1846.91% → -47.27%)
Year-over-year change
High-resolution chart · PNG
EBS operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -47.2744% | |
| -201.7857% | |
| 197.2466% | |
| -101.4964% | |
| 124% | |
| 82.1086% | |
| -348.9097% | |
| 156.1667% | |
| 141.521% | |
| 65.9783% | |
| -65.4095% | |
| 181.0811% | |
| -633.3333% | |
| -393.2976% | |
| -71.7933% | |
| -543.1138% | |
| 47.4747% | |
| -831.3725% | |
| 34.2309% | |
| -84.1255% | |
| -123.2213% | |
| -91.1765% | |
| 100.7371% | |
| 3,493.5484% | |
| 457.2626% | |
| -44.8473% | |
| 173.6589% | |
| -101.7819% | |
| -203.5221% | |
| 10,675.1766% | |
| -309.9581% | |
| 419.09% | |
| -35.9616% | |
| -102.3782% | |
| 960.5952% | |
| 24.2309% | |
| 2,656.9129% | |
| 10.2553% | |
| -398.8274% | |
| -74.2476% | |
| -184.3787% | |
| 157.3756% | |
| -94.0758% | |
| 32.7357% | |
| -76.8648% | |
| -125.2453% | |
| 499.7107% | |
| 31.2649% | |
| -67.0434% | |
| -532.1876% | |
| 120.5807% | |
| 28.2065% | |
| 73.5829% | |
| -129.2415% | |
| -208.8736% | |
| 869.7477% | |
| 380.0948% | |
| 171.7298% | |
| 59.5004% | |
| -91.0729% | |
| -278.0591% | |
| -226.7456% | |
| 203.8262% | |
| 62.503% | |
| -91.74% | |
| 168.384% | |
| -95.0498% | |
| 67.1564% | |
| 957.5443% | |
| -406.0859% | |
| -115.0855% | |
| 297.2992% | |
| 115.2998% | |
| -134.0051% | |
| 1,846.9127% |